Registry for pulmonary hypertension in lung cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the occurrence and implications of pulmonary hypertension in patients diagnosed with lung cancer. Data will be collected from all lung cancer patients treated at the University Hospital Giessen, focusing on identifying pulmonary hypertension as a potential comorbidity. The study will analyze existing treatment data without any interventions, serving as a prospective registry for these patients. The findings may provide insights into the relationship between lung cancer and pulmonary hypertension.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient with lung cancer at the University of Giessen lung Cancer Center.

Exclusion Criteria:

\-

Where it's running

• University hospital Giessen
  Giessen, Hesse, Germany Recruiting

Study contacts

• Principal investigator: Bastian Eul, MD — JLU Giessen
• Study coordinator: Bastian Eul, MD
• Email: bastian.eul@innere.med.uni-giessen.de
• Phone: (+49) 0641/985-42371

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adjusting ventilator PEEP to improve lung compliance and heart function in preterm infants

  We will try changing the ventilator's PEEP settings in babies born before 34 weeks who need breathing support to see if the PEEP that gives the best lung compliance improves heart output and oxygen levels.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT06512935

• Registry for patients with pulmonary hypertension linked to interstitial lung disease

  This study is collecting information from patients with pulmonary hypertension linked to interstitial lung disease to see how different treatments affect their health over time.

  Recruiting at 71 sites United Therapeutics · Birmingham, Alabama and 70 other locations · NCT06388421

• Using LAM-001 to treat pulmonary hypertension

  This study is testing a new treatment called LAM-001 to see if it can help people with pulmonary hypertension feel better when added to their regular care.

  Recruiting at 2 sites Phase 2 IRulya Therapeutics Inc. · Tucson, Arizona and 3 other locations · NCT05798923

• Registry and biorepository for pulmonary hypertension patients

  This study is setting up a collection of health information and blood samples from people with pulmonary hypertension to help researchers learn more about the disease and improve treatments.

  Recruiting University of Kansas Medical Center · Kansas City, Kansas · NCT04808596

• Collagen fingerprinting to stratify pulmonary hypertension in chronic lung disease

  This project tests whether fragments of non-classical collagens in blood and lung tissue can help detect and sort pulmonary hypertension in people with COPD or pulmonary fibrosis.

  Recruiting Medical University of Graz · Graz, Styria · NCT07498244

• Effects of Pioglitazone on Pulmonary Hypertension from Lung Disease

  This study is testing if the medication Pioglitazone can help people with pulmonary hypertension caused by chronic lung disease feel better and improve their oxygen use.

  Recruiting Phase 2 Emory University · Atlanta, Georgia · NCT06336798

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.